-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Downgrades PROCEPT BioRobotics to Neutral, Lowers Price Target to $38

Benzinga·12/08/2025 13:16:04
Listen to the news
B of A Securities analyst Craig Bijou downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy to Neutral and lowers the price target from $55 to $38.